Our results indicate that treatment of human monocytic leukemia cell line, THP-1, cells with 8 nM PMA for 72 h promotes a differentiation phenotype that is characterized by morphological changes and altered IFNα gene induction. The gene discussed is IFNA1; the disease is monocytic leukemia.